Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Plos One|March 3, 2012
Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumorNataly Tarasenko, Suzanne M Cutts, Don R Phillips, et al.
American Journal of Medical Genetics. Part A|April 23, 2004
Gene responsible for mitochondrial myopathy and sideroblastic anemia (MSA) maps to chromosome 12q24.33Kari Casas, Yelena Bykhovskaya, Emebet Mengesha, et al.
Seminars in Thrombosis and Hemostasis|August 25, 2016
Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and SuccessesManuel Carcao, Katsuyuki Fukutake, Aida Inbal, et al.
Fertility and Sterility|March 2, 2002
Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndromeMordechai Dulitzky, Shlomo B Cohen, Aida Inbal, et al.
Thrombosis and Haemostasis|July 29, 2010
Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophagesDániel Töröcsik, Lajos Szeles, György Paragh, et al.
Cell Death & Disease|August 12, 2016
Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular trapsKrisztián Csomós, Endre Kristóf, Bernadett Jakob, et al.
Thrombosis and Haemostasis|March 10, 2006
Evaluation of the pro-angiogenic effect of factor XIII in heterotopic mouse heart allografts and FXIII-deficient miceRima Dardik, Jonathan Leor, Ehud Skutelsky, et al.
Investigational New Drugs|September 24, 2010
The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activityNataly Tarasenko, Gania Kessler-Icekson, Pnina Boer, et al.
Leukemia & Lymphoma|October 14, 2016
Ponatinib reduces viability, migration, and functionality of human endothelial cellsAyala Gover-Proaktor, Galit Granot, Saar Shapira, et al.
Thrombosis and Haemostasis|February 16, 2018
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit DeficiencyManuel Carcao, Carmen Altisent, Giancarlo Castaman, et al.
Pageof 4